Initial Effects of COVID-19 on Patients with ESKD

Significance Statement Although reports from around the world have indicated the case fatality rate of novel coronavirus disease 2019 (COVID-19) among patients with ESKD is between 20% and 30%, the population-level effect of COVID-19 is uncertain. In a retrospective analysis of data from the Centers for Medicare and Medicaid Services, during epidemiologic weeks 13–27 of 2020, adjusted relative rates of death were 17% higher among patients...